Results 51 to 60 of about 294,840 (306)

Synthesis and characterization of spherical amorphous alumo-silicate nanoparticles using RF thermal plasma method

, 2013
The RF thermal plasma synthesis route was used for the preparation of alumo-silicate spherical particles. Homogeneous solid mixtures of raw materials (Al2O3, SiO2 and KOH) were used as precursors.
Tarakinac, Nadezda V., Jankeviciute, A., Jankeviciutea, Audrone, Károly, Zoltán, Károly, Z., Tarakina, N. ; https://orcid.org/, Kareiva, A., Kareivaa, Aivaras, Szépvölgyi, J., Szépvölgyi, János   +9 more
core   +1 more source

Non-thermal plasma enhances performances of biochar in wastewater treatment and energy storage applications

, 2021
Surface functionalization or modification to introduce more oxygen-containing functional groups to biochar is an effective strategy for tuning the physico-chemical properties and promoting follow-up applications.
Weerasinghe, Janith, Wang, Xiaoxiang, Zhou, Renwu, Wang, Hongxia, Cullen, Patrick, Zhang, Tianqi, Zhou, Rusen, Xin, Yanbin, Ostrikov, Kostya Ken, Wang, Hao   +9 more
core   +1 more source

Phosphoinositides and inositol phosphates as molecular glues

FEBS Letters, EarlyView.
Inositol phosphates (IPs) and phosphoinositides (PIPs) regulate diverse eukaryotic processes. Beyond recruiting signaling proteins or acting as structural cofactors, recent studies suggest they mediate protein–protein interactions as natural molecular glues.
Aleshia Seaton‐Terry, Alexander J. Cutright, Mong Na Claire Loi, Jessica Martin, Joseph W. Gilligan, Jakub N. Kubina, Michael J. Arambula, Susanna Tanada Palmu, Daniella Zhou, Raymond D. Blind   +9 more
wiley   +1 more source

Research Progress in the Application of Cold Plasma Sterilization Technology in Dairy Products [PDF]

Shipin Kexue
Cold plasma (or non-thermal plasma) is one of the popular non-thermal processing technologies in recent years. Cold plasma technology is expected to be used as a rapid non-thermal sterilization technology in dairy processing. However, an unoptimized cold
QI Geqi, ZHU Jun, DENG Haoguo, ZHANG Hai, XU Rihua
doaj   +1 more source

Aurora Borealis in dentistry: The applications of cold plasma in biomedicine

Materials Today Bio, 2022
Plasma is regularly alluded to as the fourth form of matter. Its bounty presence in nature along with its potential antibacterial properties has made it a widely utilized disinfectant in clinical sciences.
S. Lata, Shibani Chakravorty, Tamoghni Mitra, Prasanti Kumari Pradhan, Soumyakanta Mohanty, Paritosh Patel, Ealisha Jha, Pritam Kumar Panda, Suresh K. Verma, Mrutyunjay Suar   +9 more
doaj   +1 more source

Three phosphatase families form a community: The phosphohydrolases that act upon inositol pyrophosphates

FEBS Letters, EarlyView.
Inositol pyrophosphates are energy‐rich signaling molecules that perform critical functions in cells. Three different families of phosphatases hydrolyze the β phosphate of the inositol pyrophosphate molecules: two have narrow specificities and one is promiscuous.
Ronda J. Rolfes
wiley   +1 more source

Differential data on the responsiveness of multiple cell types to cell death induced by non-thermal atmospheric pressure plasma-activated solutions

Data in Brief, 2021
A discovery that cells die of a novel and distinctive process, along with some characteristic events, such as cellular shrinkage and Programmed cell death 4 disappearance, has been done by using non-thermal atmospheric pressure plasma-activated solutions
Ko Eto, Chiaki Ishinada, Takuya Suemoto, Keiichiro Hyakutake, Hiromasa Tanaka, Masaru Hori   +5 more
doaj   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source